Back
Reata Pharmaceuticals Stock Price Chart
See What One Ticker... One Trade... EVERY WEEK...Can Do for YOU
Show me one ticker payouts.
Buy
66
RETA
Reata Pharmaceuticals
Last Price:
169.28
Seasonality Move:
38.26%
7 Day Trial
ALL ACCESS PASS
$
7
Prepare now for a ChatGPT IPO announcement
Click here to see more- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RETA is experiencing slight buying pressure.
Reata Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 168.96 | Buy |
| 20-day SMA: | 168.55 | Buy |
| 50-day SMA: | 137.83 | Buy |
| 200-day SMA: | 85.01 | Buy |
| 8-day EMA: | 168.88 | Buy |
| 20-day EMA: | 164.06 | Buy |
| 50-day EMA: | 144.4 | Buy |
| 200-day EMA: | 97.2 | Buy |
Reata Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.09 | Buy |
| Relative Strength Index (14 RSI): | 82.05 | Buy |
| Chaikin Money Flow: | 73208 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (166.89 - 169.33) | Buy |
| Bollinger Bands (100): | (84.53 - 147.75) | Buy |
Reata Pharmaceuticals Technical Analysis
| Aug 21 | Aug 22 | Aug 23 | Aug 24 | Aug 25 | Aug 28 | Aug 29 | Aug 30 | Aug 31 | Sep 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Reata Pharmaceuticals Stock
Is Reata Pharmaceuticals Stock a Buy?
- Reata Pharmaceuticals share price is 169.26 while RETA 8-day simple moving average is 168.96, which is a Buy signal.
- The stock price of RETA is 169.26 while Reata Pharmaceuticals 20-day SMA is 168.55, which makes it a Buy.
- Reata Pharmaceuticals 50-day simple moving average is 137.83 while RETA share price is 169.26, making it a Buy technically.
- RETA stock price is 169.26 and Reata Pharmaceuticals 200-day simple moving average is 85.01, creating a Buy signal.
RETA Technical Analysis vs Fundamental Analysis
Buy
66
Reata Pharmaceuticals (RETA)
is a Buy
Is Reata Pharmaceuticals a Buy or a Sell?
-
Reata Pharmaceuticals stock is rated a Buy
The current Reata Pharmaceuticals [RETA] share price is $169.26. The Score for RETA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
Reata Pharmaceuticals Stock Info
Market Cap:
6.46B
Price in USD:
169.26
Share Volume:
366.04K
Reata Pharmaceuticals 52-Week Range
52-Week High:
169.75
52-Week Low:
21.83
Buy
66
Reata Pharmaceuticals (RETA)
is a Buy
Reata Pharmaceuticals Share Price Forecast
-
What is the Reata Pharmaceuticals stock price today?
The Reata Pharmaceuticals stock price is 169.26 USD today. -
Will RETA stock go up or go down?
Reata Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Reata Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Reata Pharmaceuticals is not overvalued.
Is Reata Pharmaceuticals Stock a Buy?
- Reata Pharmaceuticals share price is 169.26 while RETA 8-day exponential moving average is 168.88, which is a Buy signal.
- The stock price of RETA is 169.26 while Reata Pharmaceuticals 20-day EMA is 164.06, which makes it a Buy.
- Reata Pharmaceuticals 50-day exponential moving average is 144.40 while RETA share price is 169.26, making it a Buy technically.
- RETA stock price is 169.26 and Reata Pharmaceuticals 200-day simple moving average is 97.20, creating a Buy signal.
Fundamental Analysis of Reata Pharmaceuticals
Is Reata Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.68 per share, and an increase next year of $5.58 per share.
Technical Analysis of Reata Pharmaceuticals
Should I short Reata Pharmaceuticals stock?
- RETA Moving Average Covergence Divergence (MACD) indicator is 8.09, suggesting Reata Pharmaceuticals is a Buy
- Reata Pharmaceuticals Relative Strength Index (RSI) is 82.05, which suggest Reata Pharmaceuticals is overbought
- The Bollinger Bands (25) for Reata Pharmaceuticals is (166.89 - 169.33), which suggest Reata Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Reata Pharmaceuticals is (84.53 - 147.75), which suggest Reata Pharmaceuticals is a Buy
* Reata Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.